Jessica Hyman
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Computational Drug Discovery Methods, Virus-based gene therapy research, Synthesis and biological activity
Most-Cited Works
- → BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact(2014)539 cited
- → PD ‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐ PD ‐1/ PD ‐ L 1 clinical trials(2014)389 cited
- → Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma(2014)381 cited
- → Dynamics of Chemokine, Cytokine, and Growth Factor Serum Levels in BRAF-Mutant Melanoma Patients during BRAF Inhibitor Treatment(2014)79 cited
- → Intrapatient Homogeneity of BRAFV600E Expression in Melanoma(2013)74 cited
- → Lymphomagenesis in SCID-X1 Mice Following Lentivirus-mediated Phenotype Correction Independent of Insertional Mutagenesis and γc Overexpression(2010)56 cited
- → Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis(2017)20 cited
- → Isolation of the Bacteriophage DinoHI from Dichelobacter nodosus and its Interactions with other Integrated Genetic Elements(2008)7 cited
- → Coherence analysis discriminates between retroviral integration patterns in CD34+ cells transduced under differing clinical trial conditions(2015)1 cited
- Analysis and comparison of γ-retroviral vector integration behaviour in human CD34+cells transduced under conditions employed in the French and English SCID-X1 clinical trials(2013)